Cargando…

Adjuvant chemotherapy for operable breast cancer: old vs new schema

Detalles Bibliográficos
Autores principales:	Valagussa, P, Gianni, L, Bonadonna, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231905/ http://dx.doi.org/10.1186/bcr1225

Ejemplares similares

Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients
por: Retsky, Michael, et al.
Publicado: (2004)

Primary chemotherapy for operable breast cancer: the NSABP experience
por: Bear, HD
Publicado: (2005)

Consensual vs. coercive treatment: new manifestations of an old dilemma
por: Appelbaum, Paul
Publicado: (2007)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial
por: Rodenhuis, S, et al.
Publicado: (2005)

Does surgery modify growth kinetics of breast cancer micrometastases?
por: Demicheli, R, et al.
Publicado: (2001)

Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
por: Boyd, Kathleen A, et al.
Publicado: (2011)

Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
por: Chen, Wanjing, et al.
Publicado: (2021)

Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy
por: Roy, R, et al.
Publicado: (2010)

Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour
por: Demicheli, Romano, et al.
Publicado: (2004)

Surgical management of women with screen-detected breast cancer: preoperative factors indicating risk of multiple operations versus a single operation in women undergoing surgery for screen detected breast cancer
por: Currie, RJ, et al.
Publicado: (2009)

Gene pathways associated with prognosis and chemotherapy sensitivity in different molecular subtypes of breast cancer
por: Pusztai, L
Publicado: (2011)

Successful heart transplantation as third cardiac operation in a 12 year-old Marfan patient
por: Pólos, M, et al.
Publicado: (2013)

Adjuvant therapy in colorectal cancer – studies of the FOGT group
por: Staib, Ludger, et al.
Publicado: (2010)

Ultrasound elastography as an adjuvant to conventional ultrasound in the preoperative assessment of axillary lymph nodes in suspected breast cancer: a pilot study
por: Taylor, K, et al.
Publicado: (2010)

Ultrasound and fine needle aspiration assessment of the axilla in patients with operable invasive breast cancer
por: Stewart, VR, et al.
Publicado: (2006)

Complement and autoimmunity: new insights into old questions
por: Holers, VM, et al.
Publicado: (2004)

Developing new treatments for breast cancer
por: Lane, D
Publicado: (2004)

Cyclic CMP and cyclic UMP: new (old) second messengers
por: Seifert, Roland, et al.
Publicado: (2011)

Prognostic studies in patients with high-risk primary breast cancer (HRPBC) receiving high-dose chemotherapy (HDC)
por: Nieto, Y
Publicado: (2005)

The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
por: Aloia, Andrea, et al.
Publicado: (2015)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Rationale for adjuvant measures in musculoskeletal diseases
por: Gast, Ulf
Publicado: (2013)

Classical versus new prognostic factors for adjuvant treatment selection based on line software to estimate risk and benefit
por: Ravdin, PM
Publicado: (2005)

58. COMPARISON OF RADIATION PROTOCOLS FOR PRE-PECTORAL VS. SUB-PECTORAL IMPLANT-BASED BREAST RECONSTRUCTION
por: Copeland-Halperin, Libby R., et al.
Publicado: (2022)

Absence vs. presence
por: Ramkumar, Swaminathane
Publicado: (2014)

Controversies in hormonal adjuvant therapy for premenopausal patients
por: Howell, A
Publicado: (2009)

Controversies in the hormonal adjuvant therapy of postmenopausal patients
por: Dowsett, M
Publicado: (2009)

Validation of a new automated volumetric breast density measurement system as a marker of breast cancer risk
por: Pinker, K, et al.
Publicado: (2010)

Targeting new therapies in combination with hormonal therapies for ER-positive breast cancer
por: Dowsett, M
Publicado: (2005)

Translating breast cancer research into clinical practice — new approaches and better outcomes
por: Johnston, SRD
Publicado: (2006)

SOLTI (Solid Tumor Intensification) Group experience with high-dose chemotherapy treatment for early breast carcinoma
por: Funes, H Cortés, et al.
Publicado: (2005)

Apoptotic chemotherapies
por: Pardee, AB, et al.
Publicado: (2005)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

S1.2c Diagnosis of fungal infections in animals: Combining the old and the new to maximize results
por: Peano, Andrea
Publicado: (2022)

Immunity and autoimmunity in breast cancer
por: Curigliano, G
Publicado: (2011)

Semantics vs. statistics in chemical markup
por: Batchelor, Colin
Publicado: (2012)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fvrn75mc4k0ntq8drf807lgt43